Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.
about
Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremiaPropensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.Age-Related Trends in Adults with Community-Onset Bacteremia.
P2860
Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clinical Benefit of Appropriat ...... eration-Cephalosporin Therapy.
@en
Clinical Benefit of Appropriat ...... eration-Cephalosporin Therapy.
@nl
type
label
Clinical Benefit of Appropriat ...... eration-Cephalosporin Therapy.
@en
Clinical Benefit of Appropriat ...... eration-Cephalosporin Therapy.
@nl
prefLabel
Clinical Benefit of Appropriat ...... eration-Cephalosporin Therapy.
@en
Clinical Benefit of Appropriat ...... eration-Cephalosporin Therapy.
@nl
P2093
P2860
P356
P1476
Clinical Benefit of Appropriat ...... neration-Cephalosporin Therapy
@en
P2093
Chih-Chia Hsieh
Ching-Chi Lee
Chung-Hsun Lee
Hung-Jen Tang
Ming-Yuan Hong
Wen-Chien Ko
Yuan-Pin Hung
P2860
P356
10.1128/AAC.02174-16
P407
P577
2017-01-24T00:00:00Z